Morgan Stanley Issues Positive Forecast for Globus Medical (NYSE:GMED) Stock Price
Globus Medical (NYSE:GMED – Free Report) had its target price lifted by Morgan Stanley from $74.00 to $83.00 in a report released on Monday morning,Benzinga reports. Morgan Stanley currently has an equal weight rating on the medical device company’s stock. Several other research firms have also recently weighed in on GMED. Stifel Nicolaus raised their […]
More Stories
Zions Bancorporation N.A. Increases Stock Position in Woodward, Inc. (NASDAQ:WWD)
Zions Bancorporation N.A. boosted its stake in shares of Woodward, Inc. (NASDAQ:WWD – Free Report) by 17.9% during the third...
Zions Bancorporation N.A. Cuts Stock Position in Vanguard FTSE All-World ex-US ETF (NYSEARCA:VEU)
Zions Bancorporation N.A. trimmed its stake in shares of Vanguard FTSE All-World ex-US ETF (NYSEARCA:VEU – Free Report) by 1.0%...
Bell Bank Grows Position in Tesla, Inc. (NASDAQ:TSLA)
Bell Bank boosted its position in Tesla, Inc. (NASDAQ:TSLA – Free Report) by 8.5% in the 3rd quarter, according to...
Vanguard ESG US Stock ETF (BATS:ESGV) Shares Sold by Bell Bank
Bell Bank lowered its stake in shares of Vanguard ESG US Stock ETF (BATS:ESGV – Free Report) by 2.8% during...
Cable Hill Partners LLC Grows Stock Holdings in Anheuser-Busch InBev SA/NV (NYSE:BUD)
Cable Hill Partners LLC grew its stake in shares of Anheuser-Busch InBev SA/NV (NYSE:BUD – Free Report) by 5.6% during...
Zacks Research Predicts Increased Earnings for Raymond James
Raymond James (NYSE:RJF – Free Report) – Research analysts at Zacks Research raised their Q1 2025 earnings per share (EPS)...